These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17710071)

  • 21. COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors.
    van der Linden MW; Gaugris S; Kuipers EJ; van Herk-Sukel MP; van den Bemt BJ; Sen SS; Herings RM
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):880-90. PubMed ID: 19593747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevention of vascular thrombosis and risk of gastrointestinal complications].
    Karateev AE; Nasonov EL
    Ter Arkh; 2007; 79(5):84-9. PubMed ID: 17672083
    [No Abstract]   [Full Text] [Related]  

  • 23. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.
    Bhatt DL; Scheiman J; Abraham NS; Antman EM; Chan FK; Furberg CD; Johnson DA; Mahaffey KW; Quigley EM; Harrington RA; Bates ER; Bridges CR; Eisenberg MJ; Ferrari VA; Hlatky MA; Kaul S; Lindner JR; Moliterno DJ; Mukherjee D; Schofield RS; Rosenson RS; Stein JH; Weitz HH; Wesley DJ; ; ;
    Am J Gastroenterol; 2008 Nov; 103(11):2890-907. PubMed ID: 18853965
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of gastroprotection in patients discharged from hospital on nonsteroidal anti-inflammatory drugs.
    Coté GA; Norvell JP; Rice JP; Bulsiewicz WJ; Howden CW
    Am J Ther; 2008; 15(5):444-9. PubMed ID: 18806520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Non steroidal anti-inflammatory drugs (NSAIDs) - balancing gastrointestinal complications and the cardiovascular risk].
    Kandulski A; Venerito M; Malfertheiner P
    Dtsch Med Wochenschr; 2009 Aug; 134(33):1635-40; quiz 1641-4. PubMed ID: 19650027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The brave new world of antiplatelet therapy: seeking clarity in a world of increasing choice and complexity.
    Price MJ
    Rev Cardiovasc Med; 2011; 12 Suppl 1():S1-3. PubMed ID: 22080982
    [No Abstract]   [Full Text] [Related]  

  • 27. [Not Available].
    Krüger K
    Dtsch Med Wochenschr; 2017 Nov; 142(23):1773-1774. PubMed ID: 29145683
    [No Abstract]   [Full Text] [Related]  

  • 28. [Not Available].
    Korsten P; Müller GA
    Dtsch Med Wochenschr; 2017 Nov; 142(23):1775-1777. PubMed ID: 29145684
    [No Abstract]   [Full Text] [Related]  

  • 29. Over-the-counter nonsteroidal anti-inflammatory drugs and risk of gastrointestinal symptoms.
    Sangha S; Oviedo JA
    Am J Gastroenterol; 2003 May; 98(5):1203-4; author reply 1204. PubMed ID: 12809852
    [No Abstract]   [Full Text] [Related]  

  • 30. Trying times for painkiller choices. Vioxx, Bextra, and Celebrex can increase the risk for heart attack and other cardiovascular problems. So can the old standbys, like ibuprofen and acetaminophen.
    Harv Heart Lett; 2006 Oct; 17(2):1-3. PubMed ID: 17153752
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of physician education and computer alert to improve targeted use of gastroprotection among NSAID users.
    Coté GA; Rice JP; Bulsiewicz W; Norvell JP; Christensen K; Bobb A; Postelnick M; Howden CW
    Am J Gastroenterol; 2008 May; 103(5):1097-103. PubMed ID: 18477341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular disease and the dental team.
    Muzyka BC
    Pract Proced Aesthet Dent; 2005 Apr; 17(3):174. PubMed ID: 15974035
    [No Abstract]   [Full Text] [Related]  

  • 33. Management of non steroidal anti-inflammatory drug induced gastro-intestinal damage.
    McCormack PM
    Ir Med J; 1994; 87(2):27-8. PubMed ID: 8194941
    [No Abstract]   [Full Text] [Related]  

  • 34. NICE risk factors for gastrointestinal adverse events in diclofenac users in general practice in Germany: comment on the article of Thompson et al.
    Zeidler H; May M; Uberall MA; Vergin H
    Rheumatology (Oxford); 2006 Apr; 45(4):494-5. PubMed ID: 16484292
    [No Abstract]   [Full Text] [Related]  

  • 35. Are cyclooxygenase-2 inhibitors being taken only by those who need them?
    Kaufman DW; Kelly JP; Rosenberg L; Anderson TE; Mitchell AA
    Arch Intern Med; 2005 May; 165(9):1066-7. PubMed ID: 15883248
    [No Abstract]   [Full Text] [Related]  

  • 36. Nonsteroidal anti-inflammatory drugs and lower gastrointestinal complications.
    Lanas A; Sopeña F
    Gastroenterol Clin North Am; 2009 Jun; 38(2):333-52. PubMed ID: 19446262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Side effects of treatment with non-steroidal antiinflammatory agents and ways of their corrections].
    Grebneva LS; Nasonova SV; Tsvetkov LI
    Klin Med (Mosk); 1997; 75(5):42-5. PubMed ID: 9235408
    [No Abstract]   [Full Text] [Related]  

  • 38. Aspirin in cardiology--benefits and risks.
    Björklund L; Wallander MA; Johansson S; Lesén E
    Int J Clin Pract; 2009 Mar; 63(3):468-77. PubMed ID: 19222632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Nonsteroidal-anti-inflammatory drugs and serious undesirable gastrointestinal effects].
    Fabijanić D; Kardum D; Banić M; Fabijanić A
    Lijec Vjesn; 2007; 129(6-7):205-13. PubMed ID: 18018712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonsteroidal anti-inflammatory drug-induced gastrointestinal damage. Current insights into patient management. Proceedings of a symposium. June 13, 1987, Washington, D.C.
    Am J Med; 1988 Feb; 84(2A):1-52. PubMed ID: 3348237
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.